Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 206

Results For "disease"

2313 News Found

Curadev Pharma partners with CMC Vellore for dengue research
Healthcare | November 11, 2021

Curadev Pharma partners with CMC Vellore for dengue research

The company will provide the technical and financial resources to support the study


Clinical study shows ViroStop spray prevents Covid-19
News | November 11, 2021

Clinical study shows ViroStop spray prevents Covid-19

Evidence also shows better immune response to virus among users of spray


LifeCell Diagnostics expands newborn screening portfolio
Clinical Trials | November 11, 2021

LifeCell Diagnostics expands newborn screening portfolio

LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns


Medtronic first to launch cryoballoon catheter in India
Medical Device | November 10, 2021

Medtronic first to launch cryoballoon catheter in India

Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation


Takeda receives the Arogaya CIBioD Leadership Award
Public Health | November 10, 2021

Takeda receives the Arogaya CIBioD Leadership Award

It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients


Clarivate and BARDA collaborate to identify therapeutics that can be repurposed for medical countermeasures
Biotech | November 09, 2021

Clarivate and BARDA collaborate to identify therapeutics that can be repurposed for medical countermeasures

Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries


Bristol Myers neoadjuvant Opdivo (nivolumab) plus chemotherapy assists cancer patients effectively
Biotech | November 09, 2021

Bristol Myers neoadjuvant Opdivo (nivolumab) plus chemotherapy assists cancer patients effectively

Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma


Sanofi to invest up to US $ 60 million in Gyroscope
Startup | November 09, 2021

Sanofi to invest up to US $ 60 million in Gyroscope

A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).


UK authorises first Covid-19 pill
News | November 05, 2021

UK authorises first Covid-19 pill

Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency


Novavax files emergency use listing with WHO for Covid-19 vaccine
Biotech | November 05, 2021

Novavax files emergency use listing with WHO for Covid-19 vaccine

All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO